The company, helmed by BioNTech alums, is developing therapies aimed at dermatological, respiratory and gut-related ...

The recent surge has been due to the tremendous growth Lilly has achieved due to its highly popular GLP-1 drugs, including ...

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Eli Lilly (LLY) stock and Novo Nordisk (NVO) stock face investor scrutiny as RFK Jr. takes the leadership of HHS. Read more ...

We recently compiled a list of the 14 Best Large Cap Dividend Growth Stocks To Buy Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against the ...

We recently published a list of the 12 Best Long-Term Growth Stocks to Buy Now. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best ...

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » For years, Eli Lilly has been generating solid growth ...

Learn More » Let's take a closer look at the company's results to see if the stock is a buy. After reducing its guidance last month, Eli Lilly's revenue came pretty much in line with its lowered ...

We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where Eli ...

In the fourth quarter of 2024, Eli Lilly and Company (NYSE:LLY) experienced a 45% surge in revenue, reaching $13.53 billion, fueled by strong sales from Mounjaro and Zepbound. Earnings per share ...